#uk-healthcare

#uk-healthcare

Plastic surgery trends in 2024 emphasize a youthful, natural look, influenced heavily by celebrity culture and social media.

Hair transplant costs in London have risen significantly, prompting many patients to seek affordable, quality options abroad, especially in Istanbul.

The UK is exploring pilot schemes to improve obesity care with pharmaceutical companies, focusing on economic outcomes rather than individual health benefits.

Patients with advanced breast cancer in the UK are denied Enhertu, a drug that could extend their lives, due to funding decisions by NICE.

Pharmacies in the UK are considering reducing hours due to funding cuts, potentially straining public health services further.

The UK will see a significant rise in informal caregivers by 2035, highlighting a growing social care crisis.

Governments are updating legislation for non-surgical cosmetic procedures, introducing a traffic light system categorizing procedures by risk level: red (high-risk), amber (medium-risk), and green (low-risk).

Cancer care in the UK is in crisis, with patients not being treated on time leading to significant delays in treatment.

Cancer waiting times in England are at their worst on record, with only 65.9% of patients starting treatment on time in December.

ARFID cases in the UK rose sevenfold in five years, affecting children, young people, and parents.

Limited specialist care for ARFID leads to delays; 8 in 10 service providers do not mention offering ARFID care.

The article discusses the rise in surgical tourism in the UK, with events like the Health Tourism Expo showcasing various surgical procedures and services available abroad.